Abiopharma

🔍 Bennett David P (Executive)

Company: Nextpower Inc. (NXT)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Sold 32,908 shares of Common Stock at $120.32 per share (Direct)
  Date: 2026-04-27 | Code: J | equity_swap_involved: 0 | shares_owned_after: 160,667.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 34,185 shares of Common Stock at $115.82 per share (Direct)
  Date: 2026-04-28 | Code: J | equity_swap_involved: 0 | shares_owned_after: 126,482.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Reflects the number of shares required to be sold pursuant to a "sell-to-cover" transaction in order to satisfy the tax withholding obligations in connection with the vesting and conversion of PSUs. These sales are mandated by the Issuer's "sell-to-cover" policy adopted by the Issuer on March 2, 2023 pursuant to the requirements of Rule 10b5-1 and its authority under its equity incentive plan, and do not represent discretionary trades by the Reporting Person.